Oxford study to trial cannabis-based medicine as treatment for psychosis
by Andrew Gregory Health editor from Science | The Guardian on (#68XRQ)
CBD is currently only prescribed for a small number of conditions such as rare, severe epilepsy
Oxford scientists are to launch a major global trial to investigate whether cannabis-based medicine can treat people with psychosis or psychotic symptoms.
Currently, cannabidiol (CBD) is only prescribed for a small number of conditions. In the UK, for example, these include rare, severe epilepsy, and vomiting or nausea caused by chemotherapy.
Continue reading...